| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3235182 | Apollo Medicine | 2008 | 5 Pages |
Abstract
CMV infection is an important concern after renal transplantation. Since it may cause acute rejection and graft loss. Advances in laboratory methods (e.g., molecular amplification techniques) and availability of effective therapeutic agents (ganciclovir foscarnet) have provided effective management of CMV infection.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
